AI Quick Read The second son of the late Iranian supreme leader, Mojtaba Khamenei, has been named as his successor, Iranian state TV reported on Sunday. US‑Israeli strikes killed Ayatollah Ali ...

Mojtaba Khamenei, son of Iran’s late supreme leader, has been named his successor, Iranian state TV reported. The announcement comes nine days after US‑Israeli strikes killed Ayatollah Ali Khamenei.

The US and Israel's assassination of Ayatollah Ali Khamenei, the Supreme Leader of Iran, has thrown the country's complex power dynamics into uncertainty. Amid the chaos, one name has surfaced as a ...

Mojtaba Hosseini Khamenei, son of Ayatollah Ali Khamenei, has reportedly been chosen as Iran's new supreme leader. Daily Mail reported on the development, citing Iranian TV network. It comes after ...

Clearly, Emam Ashour, the Al Ahly star, just can't stop making headlines for all the wrong reasons this 2025-2026 season. The Egyptian football giant seems to have grown tired of the player’s endless ...

ADEL, Ga. (WALB) – A fire broke out at Michelle’s Formal Wear early Tuesday morning, sending heavy smoke into the area of 4th Street and Burwell Avenue. According to a post shared on the store’s ...

FOR A VOTE ON THE HOUSE FLOOR. BO. THANK YOU. BREAKING NOW AT FIVE. CREWS ARE ON THE SCENE OF WHAT APPEARS TO BE A FIRE NEAR ADEL. THIS IS A LIVE PICTURE ALONG 290TH STREET, JUST WEST OF PARKWAY. WE ...

Al Ahly appears open to the possibility of letting Egyptian international midfielder Emam Ashour leave. According to information from Africa Foot, the Cairo club's management recently held a meeting ...

Adel Emam has been a much-loved fixture on the Egyptian entertainment scene for over 50 years. He has starred in over 100 films and ten plays — much of them featuring a wide range of humour, including ...

Korean biopharmaceutical company Adel announced Monday that it has secured a license-out agreement worth up to $1.04 billion with multinational health care firm Sanofi for the development and ...

Adel (ADEL), which is jointly developing an Alzheimer's disease drug candidate with Oscotec, said on the 16th that it signed a technology transfer agreement with French drugmaker Sanofi to transfer ...

ADEL-Y01, a monoclonal antibody targeting tau protein, is in Phase I trials for Alzheimer's disease, developed by ADEL and licensed to Sanofi. The ADEL-Sanofi agreement is valued at over $1.04 billion ...